Table 1.
Participant demographics
| Community jury (n=12) | SD/% | Control (n=14) | SD/% | |
|---|---|---|---|---|
| Age | ||||
| Mean | 61 | (4.8) | 62 | (4.9) |
| Number previous PSA tests | ||||
| Mean | 3.9 | (3.6) | 2.2* | (1.8) |
| Routine PSA testing saves lives | ||||
| Frequency | ||||
| Yes | 7 | (58%) | 9 | (64%) |
| No | 2 | (17%) | 2 | (14%) |
| Do not know | 3 | (25%) | 3 | (21%) |
| Education | ||||
| Frequency | ||||
| High school or less | 2 | (17%) | 4 | (28%) |
| Some university or TAFE | 4 | (33%) | 4 | (28%) |
| University/TAFE graduate | 4 | (33%) | 1 | (7%) |
| University postgraduate | 2 | (17%) | 5 | (36%) |
*n=13 (1 missing).
PSA, prostate-specific antigen; TAFE, Technical and Further Education Institutions.